About Donegal Bio Ventures
Donegal Bio Ventures is a venture capital firm founded in 2016. It is primarily based out of Nashville, United States. It primarily invests in United States based startups. Its investments are spread across Life Sciences and Healthcare sectors. Overall, Donegal Bio Ventures portfolio has seen 1 IPO and 3 acquisitions including key companies like IVIVA Medical, Eyevance and Panacea Life Sciences.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Portfolio IPOs
Portfolio Acquisitions
Donegal Bio Ventures' List of All Investments
Donegal Bio Ventures has a portfolio of 5 companies. Their most notable investments include Dominion Aesthetic Technologies and IVIVA Medical.Their portfolio spans across and United States. They have invested in Life Sciences, Healthcare. Here is the list of all investments by Donegal Bio Ventures:Dominion Aesthetic Technologies focuses on the development of medical devices in the aesthetic field. The product is mainly used for treating multiple dermatology consitions. The company claims that the system will offer non-invasive alternatives to surgical procedures.
Key facts about Dominion Aesthetic Technologies
- Founded Year: 2015
- Location: San Antonio (United States)
- Stage: Series B
- Total Funding till date: $25.5M
- Employee Count: 11 - 50 as on Jul 17, 2025
- Investors: Donegal Bio Ventures, Octane and 2 Others
- Latest Funding Round: Series B, Jan 28, 2021, $*****
- Highlight: Editors' Pick
VIVIA Medical is developing autologous tissue constructs as a solution for end-stage renal disease. Its technology is based on tissue engineering, 3D additive manufacturing, and stem cell biology. Its various technologies are organ storage solution, disease pathology modeling, and bioreactor system. They are providing a bioartificial platform for multiple therapies.
Key facts about IVIVA Medical
- Founded Year: 2013
- Location: Beverly (United States)
- Stage: Acquired
- Employee Count: 24 as on May 31, 2026
- Investors: Prime Movers Lab, Bold Capital Partners and 3 Others
- Highlight: Acquired
3. Eyevance
Key facts about Eyevance
- Founded Year: 2017
- Location: Fort Worth (United States)
- Stage: Acquired
- Employee Count: 37 as on Jul 01, 2024
- Investors: Avego and Donegal Bio Ventures
- Highlight: Acquired
Key facts about Panacea Life Sciences
- Founded Year: 2017
- Location: Golden (United States)
- Stage: Acquired
- Total Funding till date: $7M
- Employee Count: 10 as on May 31, 2026
- Investors: Donegal Bio Ventures and 22nd Century
- Latest Funding Round: Series A, Dec 17, 2019, $*****
- Highlight: Acquired
5. Exactus
Premium domain name for sale, ideal for branding and SEO. This domain offers a golden opportunity to establish a memorable and search engine optimized online presence. It's SEO friendly, incorporating key terms to boost search engine rankings. The simple and clear structure ensures it's easy for visitors to remember. Highly brandable, it's perfectly suited for building a professional and engaging business identity. Secure a valuable digital asset to enhance your brand's visibility and attract more customers. This domain is a strategic investment for businesses seeking a strong online foundation.
Key facts about Exactus
- Founded Year: 2008
- Location: Glen Allen (United States)
- Annual Revenue: $1M - $5M as on Feb 17, 2021
- Stage: Public
- Employee Count: 3 as on Apr 30, 2026
- Investors: Donegal Bio Ventures
- Latest Funding Round: Post IPO, Dec 04, 2019, $*****
- Highlight: Public
IPOs and Publicly Listed companies in Donegal Bio Ventures' Portfolio
1 of Donegal Bio Ventures' portfolio company became public - Exactus. It got listed on the OTC Markets (OTCMKTS), in Dec 2015.Here are Donegal Bio Ventures' portfolio companies that went public:
Filter this listCompany | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 28, 2015 | - | - | 9344 |
Acquired companies in Donegal Bio Ventures' Portfolio
3 companies from Donegal Bio Ventures' portfolio have been acquired. The most recent acquisition was IVIVA Medical in Oct 2023 by United Therapeutics for $*****.Here are Donegal Bio Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 01, 2023 | - | - | 7815 | |
Jul 01, 2021 | - | - | 8978 | |
Sep 16, 2020 | - | - | 8954 |
